迪哲医药: 迪哲医药：内幕信息知情人登记管理制度

Core Viewpoint - The document outlines the insider information management system of Dize (Jiangsu) Pharmaceutical Co., Ltd., emphasizing the importance of confidentiality and compliance with relevant laws and regulations to protect investors' rights and ensure fair information disclosure. Group 1: Insider Information Management - The board of directors is responsible for managing insider information and must maintain accurate and complete records of insider information personnel [1][2] - Insider information personnel must not disclose or trade based on insider information before it is publicly disclosed [2][3] - The company must keep insider information personnel records for at least 10 years and submit them to the Shanghai Stock Exchange within five trading days after public disclosure [4][5] Group 2: Definition and Scope of Insider Information - Insider information refers to undisclosed information that could significantly impact the company's operations, finances, or stock market price [3][4] - Insider information personnel include company directors, senior management, major shareholders, and others who can access insider information due to their roles or relationships with the company [2][3] Group 3: Registration and Record-Keeping - The company must fill out and maintain an insider information personnel record, documenting the stages of discussions, consultations, and decisions related to insider information [5][6] - The record must include details such as the name, identification number, relationship to the company, and the time and manner in which the insider information was obtained [5][6] Group 4: Confidentiality and Accountability - The company must implement strict confidentiality measures for insider information and hold personnel accountable for any breaches [9][10] - Violations of the insider information management system may lead to disciplinary actions, including potential criminal charges for severe breaches [10][11]